Wells Fargo Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $125
Merck & Co Analyst Ratings
Citic Securities Initiates Merck & Co. at Buy With $136 Price Target
Intuitive Surgical Analyst Ratings
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $1,025 to $1,113
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $494
Eli Lilly & Co: Strategic Pricing and Market Expansion Fuel Buy Rating
Cantor Fitzgerald Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $155
Jefferies Downgrades Danaher(DHR.US) to Hold Rating, Cuts Target Price to $280
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $670
Danaher Initiated at Equal-Weight by Wells Fargo
Danaher Analyst Ratings
Eli Lilly Analyst Ratings
Hold Rating on Abbott Laboratories Amid NEC Litigation Uncertainties
Jefferies Maintains Abbott Laboratories(ABT.US) With Hold Rating, Raises Target Price to $120
Evercore ISI Raises Price Target on AbbVie to $192 From $180, Keeps Outperform Rating
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Eli Lilly & Co (LLY) Receives a Buy From Barclays
AbbVie Analyst Ratings
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344